Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Issa

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significanceEung-Seok Lee, Jean-Pierre Issa, Dianna B Roberts, et al.
British Journal of Haematology|June 27, 2007
Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndromeMasamitsu Yanada, Xuelin Huang, Guillermo Garcia-Manero, et al.
Methods in Enzymology|June 8, 2006
Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancersYinhua Yu, Robert Luo, Zhen Lu, et al.
Clinical Epigenetics|July 16, 2014
Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samplesDavid J Stewart, Maria I Nunez, Jaroslav Jelinek, et al.
Nature Communications|January 16, 2021
Cellular Heterogeneity-Adjusted cLonal Methylation (CHALM) improves prediction of gene expressionJianfeng Xu, Jiejun Shi, Xiaodong Cui, et al.
Cancer|September 19, 2008
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 yearsHagop Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Cancer|November 30, 2006
Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcomeHagop M Kantarjian, Susan O'Brien, Jianqin Shan, et al.
Scientific Reports|March 6, 2019
Microbial Colonization Coordinates the Pathogenesis of a Klebsiella pneumoniae Infant IsolateJillian L Pope, Ye Yang, Rachel C Newsome, et al.
Cancer|October 23, 2014
Results of phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemiaJean-Pierre Issa, Guillermo Garcia-Manero, Xuelin Huang, et al.
Leukemia Research|June 28, 2005
Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemiaAndreia A Canalli, Hui Yang, Sima Jeha, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significanceEung-Seok Lee, Jean-Pierre Issa, Dianna B Roberts, et al.
British Journal of Haematology|June 27, 2007
Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndromeMasamitsu Yanada, Xuelin Huang, Guillermo Garcia-Manero, et al.
Methods in Enzymology|June 8, 2006
Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancersYinhua Yu, Robert Luo, Zhen Lu, et al.
Clinical Epigenetics|July 16, 2014
Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samplesDavid J Stewart, Maria I Nunez, Jaroslav Jelinek, et al.
Nature Communications|January 16, 2021
Cellular Heterogeneity-Adjusted cLonal Methylation (CHALM) improves prediction of gene expressionJianfeng Xu, Jiejun Shi, Xiaodong Cui, et al.
Cancer|September 19, 2008
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 yearsHagop Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Cancer|November 30, 2006
Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcomeHagop M Kantarjian, Susan O'Brien, Jianqin Shan, et al.
Scientific Reports|March 6, 2019
Microbial Colonization Coordinates the Pathogenesis of a Klebsiella pneumoniae Infant IsolateJillian L Pope, Ye Yang, Rachel C Newsome, et al.
Cancer|October 23, 2014
Results of phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemiaJean-Pierre Issa, Guillermo Garcia-Manero, Xuelin Huang, et al.
Leukemia Research|June 28, 2005
Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemiaAndreia A Canalli, Hui Yang, Sima Jeha, et al.
Pageof 10